Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Saudi Arabia

4.1 Population
4.2 Per Capita Healthcare Expenses
4.3 Healthcare Expenditure


5. Saudi Arabia IVD Market (2011–2024)


6. Market Share – Saudi Arabia In Vitro Diagnostics (IVD) (2011 – 2024)

6.1 By Segments
6.2 By Disease


7. Segments – Saudi Arabia IVD Market (2011– 2024)

7.1 Immunochemistry Market
7.2 Clinical Chemistry Market
7.3 Hematology Market
7.4 Hemostasis/Coagulation Market
7.5 Microbiology Market
7.6 Molecular Diagnostic Market
7.7 Self Monitoring of Blood Glucose (SMBG) Market
7.8 Point of Care Testing (POCT) Market


8. Disease - Saudi Arabia IVD Market (2011– 2024)

8.1 Infectious
8.2 Cardiovascular
8.3 Diabetes
8.4 Oncology
8.5 Others


9. End User – Saudi Arabia IVD Market (2011– 2024)

9.1 Public Labs & Hospitals
9.2 Private Labs & Hospitals


10. Company Analysis

10.1 Roche Diagnostics

10.1.1 Overview
10.1.2 Company Initiatives
10.1.3 Sales Analysis

10.2 Abbott

10.2.1 Overview
10.2.2 Company Initiatives
10.2.3 Sales Analysis

10.3 Siemens Healthineers

10.3.1 Overview
10.3.2 Company Initiatives
10.3.3 Sales Analysis

10.4 Sysmex Corporation

10.4.1 Overview
10.4.2 Company Initiatives
10.4.3 Sales Analysis

10.5 Danaher Corporation

10.5.1 Overview
10.5.2 Company Initiatives
10.5.3 Sales Analysis



List of Figures



Figure-01: Saudi Arabia – IVD Market size (Million US$), 2018 & 2024
Figure-02: Saudi Arabia – IVD Market by Growing Diseases
Figure-03: Saudi Arabia Population (Million), 2011 – 2018
Figure-04: Forecast for Saudi Arabia Population (Million), 2019 – 2024
Figure-05: Saudi Arabia Per Capita Healthcare Expenses, 2011 – 2017
Figure-06: Saudi Arabia Healthcare Expenditure (Billion US$) , 2011 – 2017
Figure-07: Saudi Arabia IVD Market (Million US$), 2011 – 2018
Figure-08: Forecast for Saudi Arabia IVD Market (Million US$), 2019 – 2024
Figure-09: Saudi Arabia IVD Market Share by Segments (Percent), 2011 – 2018
Figure-10: Forecast for Saudi Arabia IVD Market Share by Segments (Percent), 2011 – 2018
Figure-11: Saudi Arabia – Immunochemistry Market (Million US$), 2011 – 2018
Figure-12: Saudi Arabia – Forecast for Immunochemistry Market (Million US$), 2019 – 2024
Figure-13: Saudi Arabia – Clinical Chemistry Market (Million US$), 2011 – 2018
Figure-14: Saudi Arabia – Forecast for Clinical Chemistry Market (Million US$), 2019 – 2024
Figure-15: Saudi Arabia – Hematology Market (Million US$), 2011 – 2018
Figure-16: Saudi Arabia – Forecast for Hematology Market (Million US$), 2019 – 2024
Figure-17: Saudi Arabia – Hemostasis/Coagulation Market (Million US$), 2011 – 2018
Figure-18: Saudi Arabia – Forecast for Hemostasis/Coagulation Market (Million US$), 2019 – 2024
Figure-19: Saudi Arabia – Microbiology Market (Million US$), 2011 – 2018
Figure-20: Saudi Arabia – Forecast for Microbiology Market (Million US$), 2019 – 2024
Figure-21: Saudi Arabia – Molecular Diagnostic Market (Million US$), 2011 – 2018
Figure-22: Saudi Arabia – Forecast for Molecular Diagnostic Market (Million US$), 2019 – 2024
Figure-23: Saudi Arabia – Self Monitoring of Blood Glucose (SMBG) Market (Million US$), 2011 – 2018
Figure-24: Saudi Arabia – Forecast for Self Monitoring of Blood Glucose (SMBG) Market (Million US$), 2019 – 2024
Figure-25: Saudi Arabia – Point of Care Testing (POCT) Market (Million US$), 2011 – 2018
Figure-26: Saudi Arabia – Forecast for Point of Care Testing (POCT) Market (Million US$), 2019 – 2024
Figure-27: Saudi Arabia – Infectious Disease Market (Million US$), 2011 – 2018
Figure-28: Saudi Arabia - Forecast for Infectious Disease Market (Million US$), 2019 – 2024
Figure-29: Saudi Arabia – Cardiovascular Disease Market (Million US$), 2011 – 2018
Figure-30: Saudi Arabia – Forecast for Cardiovascular Disease Market (Million US$), 2019 – 2024
Figure-31: Saudi Arabia – Diabetes Market (Million US$), 2011 – 2018
Figure-32: Saudi Arabia – Forecast for Diabetes Market (Million US$), 2019 – 2024
Figure-33: Saudi Arabia – Oncology Market (Million US$), 2011 – 2018
Figure-34: Saudi Arabia – Forecast for Oncology Market (Million US$), 2019 – 2024
Figure-35: Saudi Arabia – Other Disease Market (Million US$), 2011 – 2018
Figure-36: Saudi Arabia – Forecast for Other Disease Market (Million US$), 2019 – 2024
Figure-37: Saudi Arabia – End User Market by Public Labs (Million US$), 2011 – 2018
Figure-38: Saudi Arabia – Forecast for End User Market by Public Labs (Million US$), 2019 – 2024
Figure-39: Saudi Arabia – End User Market by Private Labs (Million US$), 2011 – 2018
Figure-40: Saudi Arabia – Forecast for End User Market by Private Labs (Million US$), 2019 – 2024
Figure-41: Saudi Arabia – End User Market by Other Labs (Million US$), 2011 – 2018
Figure-42: Saudi Arabia – Forecast for End User Market by Other Labs (Million US$), 2019 – 2024
Figure-43: KSA Insurance Market (in SAR Million) 2007 - 2015
Figure-44: Total Population in KSA in Million
Figure-45: Percentage share of Population over 60 years old
Figure-46: Countries with Highest Hypertension Prevalence Rate in MENA Regions (2014)
Figure-47: Countries with Highest Diabetes Prevalence Rate in MENA Region (2014)
Figure-48: Rising Cigar Import – 2010 - 2013
Figure-49: Percentage Split of Healthcare services in KSA 2014
Figure-50: Percentage Split of Laboratory services in KSA 2014
Figure-51: Roche Diagnostics – Global Sales (Billion US$), 2011 - 2018
Figure-52: Roche Diagnostics – Global Sales Forecast (Billion US$), 2019 - 2024
Figure-53: Abbott – Global Diagnostics Sales (Million US$), 2011 - 2018
Figure-54: Abbott – Forecast Global Diagnostics Sales (Million US$), 2019 - 2024
Figure-55: Siemens Healthineers – Net Sales (Million US$), 2011 - 2018
Figure-56: Siemens Healthineers – Forecast for Net Sales (Million US$), 2019 - 2024
Figure-57: Sysmex Corporation – Net Sales (Million US$), 2011 - 2018
Figure-58: Sysmex Corporation – Forecast for Net Sales (Million US$), 2019 - 2024
Figure-59: Danaher Corporation – Global Diagnostics Sales (Million US$), 2011 - 2018
Figure-60: Danaher Corporation – Forecast Global Diagnostics Sales (Million US$), 2019 - 2024

 

List of Tables


N/A